Condition
Poorly Differentiated Thyroid Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Poorly Differentiated Thyroid Carcinoma clinical trials that are recruiting, at sites in 3 countries (most in Sweden (1), China (1), Netherlands (1)). By phase: Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Poorly Differentiated Thyroid Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Personalized drug combos for advanced thyroid cancer | Phase 1 | Nijmegen | Recruiting | Mar 20, 2026 |
| Sacituzumab tirumotecan with or without tislelizumab for advanced thyroid cancer | — | Hangzhou, Zhejiang | Recruiting | Jul 16, 2025 |
| First human use of 177Lu‑AKIR001 for CD44v6‑positive advanced cancers | Early Phase 1 | Stockholm, Stockholm County | Recruiting | Oct 15, 2024 |
All recruiting trials (3)
-
Personalized drug combos for advanced thyroid cancer
This phase Ib study tests whether customized drug combinations, chosen from existing approved medicines based on a patient’s tumor genetics, can be safely given to people with advanced thyroid cancer when standard options are limited.
-
Sacituzumab tirumotecan with or without tislelizumab for advanced thyroid cancer
This trial tests sacituzumab tirumotecan, given alone or together with the immunotherapy tislelizumab, in adults with unresectable or metastatic anaplastic, poorly differentiated, or radioactive iodine‑refractory differentiated thyroid cancer to see if it slows disease or improves survival.
-
First human use of 177Lu‑AKIR001 for CD44v6‑positive advanced cancers
This trial tests a Lutetium‑177 radiolabeled drug (AKIR001) in adults with advanced, irresectable CD44v6‑expressing solid tumors who have no reasonable systemic treatment options.
Related topics
Quick answers
How many Poorly Differentiated Thyroid Carcinoma clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Sweden (1 trial), China (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.